The Growth of Deep Learning & Machine Learning in Cancer… : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
Follow #ESMOBreast24 on Facebook, X (Twitter), LinkedIn, Instagram and YouTube.
A list of helpful resources compiled by the British Society for Haematology to support your wellbeing and your career, especially in the early stages.
The role of autologous-allogeneic tandem stem cell transplantation (alloTSCT) followed by maintenance as upfront treatment for multiple myeloma (MM) is controversial. Between 2008 and 2014…
Amy Colada, University College London Hospital, London, UK, discusses the effectiveness of ambulatory care in place of inpatient care for patients undergoing stem cell transplantation…
The zenocutuzumab BLA for patients with NRG1-positive non–small cell lung cancer and pancreatic cancer has received priority review from the FDA.
SERENA-1 (NCT03616587) is a Phase 1, multi-part, open-label study of camizestrant in pre- and post-menopausal women with ER+, HER2− advanced breast cancer. Parts A and…
Treatment with loncastuximab tesirine yielded high response rates in patients with relapsed or refractory marginal zone lymphoma.
No significant difference in time to treatment was found between White and Black patients with bladder cancer, but there remained a difference in treatment outcomes.
Leland Metheny, MD, discusses how agents such as Iomab-B have potential to shift practice in the hematologic malignancy space.
Treatment with acalabrutinib-based regimens led to long-term benefits in patients with higher-risk CLL, across all lines of therapy.